Germany
Japan
United Kingdom
China
USD 428.00
In Stock
Products
Download
VIII mouse monoclonal antibody, clone B62-FE2, FITC
| Applications | ELISA |
| Conjugation | FITC |
USD 260.00
5 Days
Human IgG4 (pFC) mouse monoclonal antibody, clone HP6023 (also known as HO6023), HRP, Purified
| Applications | ELISA: 1/4000-1/8000 (See also Ref.2-9). Applications Reported in Literature: Flow Cytometry (Ref.15,18,19). Immunohistochemistry on Frozen Sections (Ref.10). Immunohistochemistry on Paraffin Sections (Ref.5,7,10,11). Immunocytochemistry (Ref.12). Immunoblotting (Ref.3,13-16). Microarray (Ref.17). Multiplex (Ref.2,20-22). Purification (Ref.15). |
| Reactivities | Human |
| Conjugation | HRP |
USD 300.00
5 Days
Human IgG4 (pFC) mouse monoclonal antibody, clone HP6023 (also known as HO6023), AP, Purified
| Applications | ELISA: 1/1000-1/2000 (See also Ref.2-9). FLISA. Applications Reported in Literature: Flow Cytometry (Ref.15,18,19). Immunohistochemistry on Frozen Sections (Ref.10). Immunohistochemistry on Paraffin Sections (Ref.5,7,10,11). Immunocytochemistry (Ref.12). Immunoblotting (Ref.3,13-16). Microarray (Ref.17). Multiplex (Ref.2,20-22). Purification (Ref.15). |
| Reactivities | Human |
| Conjugation | AP |
USD 180.00
In Stock
USD 260.00
2 Weeks
Parathyroid Hormone (PTH) (53-84) mouse monoclonal antibody, clone D1.5, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
MRP8/14 (S100A8/A9) mouse monoclonal antibody, clone 27E10, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
CRP mouse monoclonal antibody, clone PC1, Purified
| Applications | ELISA, WB |
| Reactivities | Porcine |
IGHG4 mouse monoclonal antibody, clone HP6025, AP, Purified
| Applications | ELISA: 1/1000-1/2000 (2-9). Immunohistochemistry on Frozen Sections: reported in literature (5,7,10,11). Immunohistochemistry on Paraffin Sections: reported in literature (10). Flow Cytometry: reported in literature (15, 18, 19). Immunocytochemistry: reported in literature (12). Western Blot: reported in literature (3,13-16). |
| Reactivities | Human |
| Conjugation | AP |
USD 250.00
2 Weeks
ICAM1 mouse monoclonal antibody, clone MEM-111, Purified
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Bovine, Human, Rat |
Canine Parvovirus mouse monoclonal antibody, clone CPV1-2A1, Purified
| Applications | ELISA, IHC |
| Reactivities | Canine, Feline |
USD 450.00
2 Weeks
Human IgA mouse monoclonal antibody, clone NI 69 (A89-034) and NI 184 (A89-035), Ascites
| Applications | To identify the presence of IgA in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as Radioimmunoassay, ELISA, Indirect Immunoperoxidase and Immunofluorescence staining of cytoplasmic IgA, Haemagglutination and Immunoblotting. General Recommended Dilutions: Histochemical Use: 1/50-1/200. ELISA: from 1/500 upwards. Western blot: from 1/1000 upwards. |
| Reactivities | Human |
USD 260.00
2 Weeks
gamma Tubulin (TUBG1) (434-449) mouse monoclonal antibody, clone TU-32, Aff - Purified
| Applications | ELISA, IF, WB |
| Reactivities | Mammalian, Plant |
USD 415.00
2 Weeks
Adeno-Associated Virus 2 / AAV2 (intact particle) mouse monoclonal antibody, clone A20, Purified
| Applications | ELISA, FN, IF, IHC, IP |
| Reactivities | Human, Monkey |
Lipoteichoic Acid (LTA) mouse monoclonal antibody, clone 55, Low Endotoxin
| Applications | ELISA, IF, IHC, WB |
USD 745.00
5 Days
ACTH (POMC) (1-24) mouse monoclonal antibody, clone 57 (BGN/1388/66), Aff - Purified
| Applications | ELISA, IHC |
| Reactivities | Human, Rat |
pan Dengue Virus mouse monoclonal antibody, clone Dengue 1-11(3), Purified
| Applications | ELISA, IF, IHC, WB |
Testosterone (3-CMO-BSA) mouse monoclonal antibody, clone 7003, Purified
| Applications | ELISA, IF, R |
| Reactivities | Human |
C1QA mouse monoclonal antibody, clone JL-1, Biotin
| Applications | ELISA, FN, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
USD 680.00
2 Weeks
Human IgG1 (Fc specific) mouse monoclonal antibody, clone NI 132 (HP 6186), Biotin
| Applications | To identify the presence of IgG1 in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, immunoperoxidase staining of cytoplasmic IgG1, and Immunoblotting. As a second step an avidin or streptavidin conjugate of the customer's choice have to be used. General Recommended Dilutions: Immunocytochemistry. Immunohistochemistry (Paraffin). Histochemical Use: 1/10-1/40. ELISA: 1/100-1/2000. Western blot: 1/200-1/4000. |
| Reactivities | Human |
| Conjugation | Biotin |
USD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Desmoglein 2 (DSG2) mouse monoclonal antibody, clone 10G11, Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
USD 340.00
2 Weeks
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone KS19.2(Z105.6), Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Amphibian, Bovine, Chicken, Human, Rat |
Tubulin (TUBA1B) (Tyr-Tubulin) rat monoclonal antibody, clone YL1/2, Purified
| Applications | ELISA, IF, IHC, IP, R, WB |
| Reactivities | Birds, Mammalian, Yeast |
beta 2 Microglobulin (B2M) mouse monoclonal antibody, clone B2M-01, HRP
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | HRP |
Hepatitis B E Antigen / HBeAg mouse monoclonal antibody, clone 774, Purified
| Applications | ELISA |
Aggrecan (ACAN) mouse monoclonal antibody, clone HAG7D4 (7D4), Purified
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Bovine, Human |
IL7 rat monoclonal antibody, clone BVD10-40F6, Purified
| Applications | ELISA |
| Reactivities | Human |
IP10 (CXCL10) mouse monoclonal antibody, clone 6D4, Biotin
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Biotin |
OVAL mouse monoclonal antibody, clone 2C6, Purified
| Applications | ELISA |
| Reactivities | Chicken |
USD 260.00
2 Weeks
Parathyroid Hormone (PTH) (1-37) mouse monoclonal antibody, clone 77/78, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
DEFB4B (4-41) mouse monoclonal antibody, clone L12-4C-C2, Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
USD 2,060.00
2 Weeks
Staphylococcus aureus (Peptidoglycan) mouse monoclonal antibody, clone 702, Biotin
| Applications | ELISA |
| Conjugation | Biotin |
USD 230.00
2 Weeks
Anti-Remicade(Infliximab) mouse monoclonal antibody, clone 103A8.03
| Applications | ELISA, FN |
| Reactivities | Human |
Active filters
Applications
- ELISA
Clonalities
- Monoclonal
Filter by
Target Symbol
- UCHL1 (124)
- S PROTEIN (122)
- LCN2 (113)
- IL6 (111)
- GFAP (105)
- IL1RL1 (104)
- N PROTEIN (101)
- IL17A (88)
- S100A8/A9 (87)
- D-DIMER (83)
- SAA1 (81)
- MPO (80)
- FABP3 (71)
- MYBPC3 (63)
- REG1A (62)
- CAPSID (50)
- NEFL (48)
- IGG4 (38)
- AMH (34)
- PDCD1 (28)
- CD80 (25)
- S (25)
- GAG (24)
- MAPT (24)
- FSHB (23)
- SARS-COV-2 SPIKE PROTEIN (22)
- NPPB (21)
- PON1 (21)
- S100B (20)
- BRAF (19)
- CD274 (19)
- F13A1 (18)
- FOLH1 (18)
- SARS-COV-2 N PROTEIN (17)
- TNF (17)
- V5 (17)
- EGFR (16)
- MUC1 (16)
- B2M (15)
- HIS (15)
- TP63 (14)
- CD5 (13)
- EFNA2 (13)
- IL2 (13)
- ALB (12)
- CD1C (12)
- CRP (12)
- EGF (12)
- EPHX1 (12)
- MSMB (12)
- NME1 (12)
- DDK (11)
- KLK8 (11)
- MAP2K1 (11)
- S100A1 (11)
- SERPINB3 (11)
- TLE1 (11)
- CSF2 (10)
- ERG (10)
- IFNG (10)
- KLK3 (10)
- LDLRAP1 (10)
- OTUB1 (10)
- PRL (10)
- VSIR (10)
- AFP (9)
- CA12 (9)
- CCR5 (9)
- CEACAM5 (9)
- CFB (9)
- HIST1H3A (9)
- LTF (9)
- PARVA (9)
- TIMP2 (9)
- TMEM173 (9)
- ALDH1L1 (8)
- CCL2 (8)
- CD33 (8)
- CD4 (8)
- CXCL8 (8)
- ENG (8)
- ENO2 (8)
- FGFR2 (8)
- IL10 (8)
- INS (8)
- MAPK8 (8)
- MYC (8)
- N (8)
- PRKCE (8)
- PSMD2 (8)
- SMS (8)
- WFDC2 (8)
- ACY1 (7)
- AKT1 (7)
- CD44 (7)
- FGF2 (7)
- FN1 (7)
- HES1 (7)
- HPGD (7)
- IKZF3 (7)
Reactivities
- Human (2925)
- Mouse (511)
- Rat (417)
- SARS-CoV-2 (257)
- HIV (49)
- Monkey (28)
- Virus (23)
- Porcine (19)
- Dog (18)
- Rabbit (17)
- Bovine (14)
- Primate (11)
- C-term DDK (10)
- Vertebrates (9)
- Goat (8)
- Pig (8)
- SARS-CoV (8)
- Feline (7)
- Sheep (7)
- Canine (6)
- Cow (6)
- Chimpanzee (5)
- Chicken (3)
- Guinea Pig (3)
- Hamster (3)
- Respiratory Syncytial Virus (3)
- Bacteria (2)
- Cynomolgus (2)
- Dengue virus (2)
- Ferret (2)
- Insect (2)
- Mammalian (2)
- N-term and C-term DDK (2)
- West Nile Virus (2)
- Yeast (2)
- Yellow Fever Virus (2)
- Zebrafish (2)
- Bacillus Antracis (1)
- Fish (1)
- Staphylococcus aureus (1)
- Xenopus (1)
Antibody Hosts
Isotypes
- IgG1 (5108)
- IgG2a (1139)
- IgG2b (909)
- IgG (416)
- IgG, kappa (166)
- IgG1, kappa (124)
- IgM (107)
- IgG3 (90)
- IgG2a, kappa (35)
- IgG2 (24)
- Fab fragment, kappa (19)
- IgG2b, kappa (15)
- IgG1, lambda (11)
- IgG1-Fc Fusion (8)
- IgG2c (6)
- IgG3, kappa (5)
- IgG4 (5)
- IgM, kappa (5)
- IgA-Fc Fusion (4)
- IgG-Fc Fusion (4)
- IgM-Fc Fusion (4)
- IgE (3)
- cocktail (3)
- IgA (2)
- IgG2, kappa (2)
- IgG2a, lambda (2)
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (47)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (6)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho-specific (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (2131)
- Secreted Protein (989)
- Transmembrane (553)
- ES Cell Differentiation/IPS (370)
- Transcription Factors (296)
- Protease (259)
- Protein Kinase (193)
- Stem cell - Pluripotency (107)
- Adult stem cells (59)
- Embryonic stem cells (40)
- Cancer stem cells (31)
- Stem cell relevant signaling - JAK/STAT signaling pathway (31)
- Induced pluripotent stem cells (28)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (19)
- Stem cell relevant signaling - DSL/Notch pathway (17)
- Phosphatase (15)
- Stem cell relevant signaling - Wnt Signaling pathway (11)
- Nuclear Hormone Receptor (10)
- Ion Channels: Other (9)
- GPCR (6)
- P450 (5)
Pathways
- Cytokine-cytokine receptor interaction (380)
- Pathways in cancer (343)
- Jak-STAT signaling pathway (221)
- Toll-like receptor signaling pathway (208)
- Hematopoietic cell lineage (201)
- Hypertrophic cardiomyopathy (HCM) (201)
- Metabolic pathways (200)
- MAPK signaling pathway (187)
- NOD-like receptor signaling pathway (162)
- Focal adhesion (155)
- Graft-versus-host disease (155)
- Prion diseases (143)
- T cell receptor signaling pathway (132)
- Prostate cancer (131)
- Parkinson's disease (129)
- ErbB signaling pathway (122)
- Cytosolic DNA-sensing pathway (121)
- Regulation of actin cytoskeleton (120)
- Chemokine signaling pathway (107)
- Colorectal cancer (106)
- Endometrial cancer (105)
- Pancreatic cancer (99)
- Neurotrophin signaling pathway (98)
- Melanoma (97)
- Bladder cancer (96)
- GnRH signaling pathway (96)
- Chronic myeloid leukemia (94)
- Cell adhesion molecules (CAMs) (91)
- Dilated cardiomyopathy (91)
- Acute myeloid leukemia (90)
- Glioma (90)
- Non-small cell lung cancer (90)
- TGF-beta signaling pathway (90)
- Insulin signaling pathway (89)
- PPAR signaling pathway (89)
- Natural killer cell mediated cytotoxicity (88)
- Progesterone-mediated oocyte maturation (87)
- Fc epsilon RI signaling pathway (83)
- Complement and coagulation cascades (81)
- Systemic lupus erythematosus (73)
- Amyotrophic lateral sclerosis (ALS) (72)
- Renal cell carcinoma (72)
- Gap junction (67)
- Endocytosis (66)
- Alzheimer's disease (64)
- Neuroactive ligand-receptor interaction (62)
- Thyroid cancer (61)
- B cell receptor signaling pathway (59)
- Type I diabetes mellitus (57)
- Vascular smooth muscle contraction (57)
- Long-term depression (56)
- Wnt signaling pathway (56)
- Cell cycle (54)
- Allograft rejection (53)
- Fc gamma R-mediated phagocytosis (52)
- Long-term potentiation (51)
- Melanogenesis (51)
- mTOR signaling pathway (51)
- Autoimmune thyroid disease (50)
- Type II diabetes mellitus (50)
- Tight junction (48)
- Adipocytokine signaling pathway (47)
- Adherens junction (45)
- VEGF signaling pathway (45)
- Axon guidance (44)
- Oocyte meiosis (43)
- Epithelial cell signaling in Helicobacter pylori infection (42)
- RIG-I-like receptor signaling pathway (40)
- Small cell lung cancer (40)
- Glycolysis / Gluconeogenesis (36)
- Viral myocarditis (36)
- Antigen processing and presentation (33)
- Apoptosis (33)
- Pathogenic Escherichia coli infection (32)
- Purine metabolism (32)
- Dorso-ventral axis formation (31)
- ECM-receptor interaction (28)
- Glutathione metabolism (27)
- Leukocyte transendothelial migration (26)
- Metabolism of xenobiotics by cytochrome P450 (26)
- Arginine and proline metabolism (24)
- Calcium signaling pathway (23)
- Cysteine and methionine metabolism (23)
- Huntington's disease (20)
- Proteasome (20)
- Pyrimidine metabolism (20)
- Pyruvate metabolism (19)
- Maturity onset diabetes of the young (18)
- Notch signaling pathway (18)
- Regulation of autophagy (17)
- p53 signaling pathway (17)
- One carbon pool by folate (16)
- Asthma (15)
- Glycine (15)
- serine and threonine metabolism (15)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (14)
- Arachidonic acid metabolism (12)
- Nitrogen metabolism (12)
- Citrate cycle (TCA cycle) (11)
- Fructose and mannose metabolism (11)
- Basal cell carcinoma (10)
- Cardiac muscle contraction (10)
- Drug metabolism - cytochrome P450 (10)
- Lysosome (10)
- Propanoate metabolism (10)
- RNA degradation (10)
- Hedgehog signaling pathway (9)
- Spliceosome (9)
- Valine (9)
- leucine and isoleucine degradation (9)
- Pentose phosphate pathway (8)
- Tryptophan metabolism (8)
- Vibrio cholerae infection (8)
- beta-Alanine metabolism (8)
- Base excision repair (7)
- Cyanoamino acid metabolism (7)
- Folate biosynthesis (7)
- Selenoamino acid metabolism (7)
- Starch and sucrose metabolism (7)
- Tyrosine metabolism (7)
- Phenylalanine metabolism (6)
- Amino sugar and nucleotide sugar metabolism (5)
- Butanoate metabolism (5)
- Drug metabolism - other enzymes (5)
- Linoleic acid metabolism (5)
- Lysine degradation (5)
- Methane metabolism (5)
- Oxidative phosphorylation (5)
- Phosphatidylinositol signaling system (5)
- Primary immunodeficiency (5)
- Terpenoid backbone biosynthesis (5)
- Biosynthesis of unsaturated fatty acids (4)
- Fatty acid metabolism (4)
- Galactose metabolism (4)
- Non-homologous end-joining (4)
- Nucleotide excision repair (4)
- Olfactory transduction (4)
- Renin-angiotensin system (4)
- SNARE interactions in vesicular transport (4)
- Ubiquitin mediated proteolysis (4)
- Alanine (3)
- Aminoacyl-tRNA biosynthesis (3)
- Caffeine metabolism (3)
- Inositol phosphate metabolism (3)
- RNA polymerase (3)
- Retinol metabolism (3)
- Riboflavin metabolism (3)
- Synthesis and degradation of ketone bodies (3)
- aspartate and glutamate metabolism (3)
- ABC transporters (2)
- Circadian rhythm - mammal (2)
- Glycerophospholipid metabolism (2)
- Glyoxylate and dicarboxylate metabolism (2)
- Histidine metabolism (2)
- Limonene and pinene degradation (2)
- Mismatch repair (2)
- Nicotinate and nicotinamide metabolism (2)
- Pantothenate and CoA biosynthesis (2)
- Ribosome (2)
- Vitamin B6 metabolism (2)
- leucine and isoleucine biosynthesis (2)
- Androgen and estrogen metabolism (1)
- C21-Steroid hormone metabolism (1)
- DNA replication (1)
- Fatty acid elongation in mitochondria (1)
- Glycerolipid metabolism (1)
- Pentose and glucuronate interconversions (1)
- Primary bile acid biosynthesis (1)
- Sphingolipid metabolism (1)
- Taurine and hypotaurine metabolism (1)